Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen

Digestion

Volumn 64, Issue 4, 2001, Pages 222-225

  Sotoudehmanesh, Rasoul ^a   Malekzadeh, Reza ^a   Vahedi, Homayoon ^a   Dariani, Nasser Ebrahimi ^a   Asgari, Ali Ali ^a   Massarrat, Sadegh ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

Furazolidone; Helicobacter pylori; Metronidazole

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; FURAZOLIDONE; METRONIDAZOLE; NITROIMIDAZOLE; OMEPRAZOLE; TETRACYCLINE;

ABDOMINAL PAIN; ADULT; ANOREXIA; ANTIBIOTIC RESISTANCE; ARTICLE; CHILL; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; DYSGEUSIA; ERADICATION THERAPY; FEMALE; FEVER; FLATULENCE; FOLLOW UP; HEADACHE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTPATIENT CARE; PRIORITY JOURNAL; TREATMENT FAILURE; UREA BREATH TEST; VERTIGO; VOMITING; XEROSTOMIA;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; FURAZOLIDONE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRAN; MALE; MEDICAL RECORDS; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PENICILLINS; RETROSPECTIVE STUDIES; TETRACYCLINE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0035713982     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048865     Document Type: Article

References (37)

1. Analysis of H. pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases
2. Effects of antibiotic resistance on clarithromycin-combined triple therapy for Helicobacter pylori
3. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment
4. One week low-dose triple therapy: New standards for Helicobacter pylori treatment
5. Antimicrobial management of Helicobacter pylori infection
6. Metronidazole and clarithromycin resistance among H. pylori isolates from a large hospital in the United States
7. Metronidazole resistance is high in Korea and Columbia and appears to be rapidly increasing in the U.S.
8. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States; Effect of age, race, and socioeconomic status
9. Effect of triple therapy or amoxicillin plus omeprazole or amoxicillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: A prospective, randomized, controlled study
10. Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance
11. Effect of acid suppression on efficacy of treatment for H. pylori infection
12. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, flurazolidone and clarithromycin triple therapy for 1 week
13. Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection
14. Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer
15. 14C-urea breath test for the detection of Helicobacter pylori
16. Current European concepts in the management of Helicobacter pylori infection
17. Furazolidone combination therapies for Helicobacter pylori infection in the United States
18. Metronidazole and clarithromycin resistance among Helicobacter pylori isolates from a large hospital in the United States
19. Randomized controlled study on the effect of omeprazole with amoxicillin in Helicobacter pylori eradication
20. Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin
21. A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rate
22. Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of H. pylori and its resistant strains
23. How to treat Helicobacter pylori infection: Should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint
24. Twice a day quadruple therapy (bismuth subcitrate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection
25. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy
26. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing
27. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones
28. Pseudomembranous colitis following clarithromycin therapy
29. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate
30. Absorption, distribution, metabolism, and excretion of furazolidone: A review of the literature
31. Treatment of peptic ulcer disease with furazolidone
32. Double-blind short-term trial of furazolidone in peptic ulcer
33. Adverse reactions to furazolidone and other drugs: A comparative review
34. Furazolidone, amoxicillin, bismuth triple therapy for Helicobacter pylori infection
35. A multicenter study on eradication of Helicobacter pylori using four 1-week triple therapies in China
36. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: A prospective randomized 1-year follow-up study
37. Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: A double-blind placebo-controlled trial